Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
561. |
ECCT/12/11/02 | Not provided A5297: An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of Plasmodium falciparum Subclinical Parasitemia in HIV-infected Adults with CD4+ Counts >200 and <350 cells/mm3 |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) |
29-02-2012 |
View |
562. |
ECCT/13/04/03 | HIV-Malaria Study_A5297 An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of Plasmodium falciparum Subclinical Parasitemia in HIV-infected Adults with CD4+ Counts >200 and <350 cells/mm3 . |
Principal Investigator(s) 1. Josphat K. Kosgei Site(s) in Kenya 1. Kemri Walter Reed Project-Kericho (Kericho county) 2. Moi University Clinical Research Centre (Uasin Gishu county) |
26-03-2013 |
View |
563. |
ECCT/13/04/09 | Short-course RPT/INH for latent TB in HIV-infected individuals Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection |
Principal Investigator(s) 1. Deborah C. Langat Site(s) in Kenya 1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county) 2. Moi University Clinical Research Centre (Uasin Gishu county) |
26-03-2013 |
View |
564. |
ECCT/08/06/01 | PARTNERS PrEP Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples |
Principal Investigator(s) 1. Elizabeth Anne Bukusi Site(s) in Kenya 1. Kisumu site (Kisumu county) |
30-07-2008 |
View |
565. |
ECCT/13/04/04 | Enteric Study A Randomized, Double-Blind, Clinical Trial Evaluating Three Single Dose Regimens with Loperamide for Treatment of Ambulatory Watery Travelers’ Diarrhea, and Azithromycin with and without Loperamide for Treatment of Ambulatory Dysentery/Febrile Diarrhea |
Principal Investigator(s) 1. CPT Brook A. Danboise Site(s) in Kenya British Army Training Unit, Kenya (BATUK) |
26-03-2013 |
View |
566. |
ECCT/11/10/01 | A RANDOMIZED PHASE IIA TRIAL OF GEMCITABINE COMPARED WITH BLEOMYCIN PLUS VINCRISTINE FOR TREATMENT OF KAPOSI’S SARCOMA IN PATIENTS ON COMBINATION ANTIRETROVIRAL THERAPY IN WESTERN KENYA. |
Principal Investigator(s) 1. NAFTALI WISINDI BUSAKHALA Site(s) in Kenya MOI UNIVERSITY CLINICAL RESEARCH SITE |
20-07-2011 |
View |
567. |
ECCT/12/04/02 | Short-course RPT/INH for latent TB in HIV-infected individuals A5279: Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) |
11-05-2011 |
View |
568. |
ECCT/11/08/05 | Rifapentine During Intensive Phase TB Treatment Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis |
Principal Investigator(s) 1. Lena Matata 2. Kevin Cain Site(s) in Kenya KEMRI/CDC-KISUMU |
02-11-2011 |
View |
569. |
ECCT/08/27/12 | MAL 55: A phase III, double blind (observer-blind), randomised, controlled multicenter study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease caused by P. falciparum infection. Protocol No. 110021 - MAL 55 STUDY A phase III, double blind (observer-blind), randomised, controlled multicenter study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease caused by P. falciparum infection, across diverse malaria transmission settings in Africa” |
Principal Investigator(s) 1. Dr. Mary Hamel 2. Dr. Patricia Njuguna 3. Dr. Walter Otieno Site(s) in Kenya 1. KEMRI - CDC RESEARCH INSTITUTION CENTRE, KISUMU (Kisumu county) 2. KEMRI-WELLCOME TRUST RESEARCH CENTER, KILIFI SITE (Kilifi county) 3. KEMRI-WALTERREED, RESEARCH CENTRE, KOMBEWA SITE (Kisumu county) |
07-12-2012 |
View |
570. |
ECCT/10/05/02 | AERAS-402 A Phase II, Double-blind, Randomized, Placebo-controlled, Multicenter, Proof-of-concept Study to Evaluate the Safety and Efficacy of AERAS-402 in BCG-vaccinated, HIV-uninfected Infants Without Evidence of Tuberculosis |
Principal Investigator(s) 1. Dr Videlis Nduba 2. Dr Grace Kiringa Kaguthi Site(s) in Kenya KEMRI-CDC |
24-06-2010 |
View |